226 related articles for article (PubMed ID: 2107257)
1. Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.
Leu RW; Zhou AQ; Shannon BJ; Herriott MJ
J Immunol; 1990 Mar; 144(6):2281-6. PubMed ID: 2107257
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of a deficiency of AKR mouse macrophages for their response to lipid A activation for tumor cytotoxicity by complement subcomponent C1q: role of IFN-gamma.
Leu RW; Zhou AQ; Rummage J; Fast DJ; Shannon BJ
J Immunol; 1991 Aug; 147(4):1315-21. PubMed ID: 1907994
[TBL] [Abstract][Full Text] [Related]
3. Exogenous C1q reconstitutes resident but not inflammatory mouse peritoneal macrophages for Fc receptor-dependent cellular cytotoxicity and phagocytosis. Relationship to endogenous C1q availability.
Leu RW; Zhou AQ; Rummage JA; Kennedy MJ; Shannon BJ
J Immunol; 1989 Nov; 143(10):3250-7. PubMed ID: 2809201
[TBL] [Abstract][Full Text] [Related]
4. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
5. Exogenous C1q reconstitutes a secondary deficiency of C5-deficient AKR mouse macrophages for FcR-dependent cellular cytotoxicity and phagocytosis.
Leu RW; Zhou AQ; Kennedy MJ; Shannon BJ
J Immunol; 1991 Feb; 146(4):1233-9. PubMed ID: 1991965
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of C1q secretion suppresses the macrophage response to lipid A for nitric oxide but not for TNF production: evidence for a role of C1q in autocrine binding of TNF.
Leu RW; Stewart CA; Herriott MJ; Fast DJ; Rummage JA
Immunobiology; 1993 Jul; 188(3):242-58. PubMed ID: 8225388
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhibitors of C1q biosynthesis on macrophage Fc receptor subclass-mediated antibody-dependent cellular cytotoxicity and phagocytosis.
Mocharla R; Mocharla H; Leu RW
Cell Immunol; 1987 Mar; 105(1):127-35. PubMed ID: 3028650
[TBL] [Abstract][Full Text] [Related]
8. Evidence for endogenous C1q modulates TNF-alpha receptor synthesis and autocrine binding of TNF-alpha associated with lipid A activation of murine macrophages for nitric oxide production.
Jiang H; Rummage JA; Stewart CA; Herriott MJ; Kolosova I; Kolosov M; Leu RW
Cell Immunol; 1996 May; 170(1):34-40. PubMed ID: 8660797
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the biosynthesis of complement subcomponent C1q by murine macrophages: effects of stimulation by interferon-gamma.
Zhou AQ; Herriott MJ; Leu RW
J Interferon Res; 1991 Apr; 11(2):111-9. PubMed ID: 1908003
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
[TBL] [Abstract][Full Text] [Related]
12. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
13. IFN-alpha beta reconstitutes the deficiency in lipid A-activated AKR macrophages for nitric oxide synthase.
Jiang H; Rummage JA; Zhou A; Chen Z; Herriot MJ; Stewart CA; Kolosov M; Leu RW
J Immunol; 1996 Jul; 157(1):305-12. PubMed ID: 8683131
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
15. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
Rüegg SJ; Jungi TW
Immunology; 1988 Mar; 63(3):513-20. PubMed ID: 2965100
[TBL] [Abstract][Full Text] [Related]
17. Relationship between murine macrophage Fc receptor-mediated phagocytic function and competency for activation for non-specific tumor cytotoxicity.
Leu RW; Rummage JA; Rahimi MB; Herriott MJ
Immunobiology; 1986 Apr; 171(3):220-33. PubMed ID: 3519439
[TBL] [Abstract][Full Text] [Related]
18. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
Munn DH; Armstrong E
Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
Chen L; Suzuki Y; Wheelock EF
J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of murine macrophage-mediated tumor cytotoxicity induced by interferons.
Koestler TP; Johnson WJ; Rieman D; Dalton BJ; Greig RG; Poste G
Cancer Res; 1987 Jun; 47(11):2804-8. PubMed ID: 2436758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
